title: Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.
abstract: OBJECTIVE
  To assess attitudes and beliefs towards benign prostatic hyperplasia (BPH)/ lower urinary tract symptoms (LUTS) and its treatment among patients and physicians in Latin America, Asia Pacific and the Commonwealth of Independent States (CIS).
  
  
  METHODS
  Cross-sectional, quantitative study conducted between December 2014 and September 2015. Separate questionnaires were administered to BPH/LUTS patients receiving drug treatment for their condition and to practising physicians who treat patients with BPH/LUTS.
  
  
  RESULTS
  In total, 1094 patients and 202 physicians completed a questionnaire. Most patients (61%) felt very/fairly well informed about BPH/LUTS, and 60% of physicians perceived patients to be very/somewhat informed. Overall, 70% of physicians felt that it would be valuable to raise awareness of BPH/LUTS and encourage men to consult a physician. The first symptoms most commonly noticed by patients were need to urinate more frequently, slower/weaker stream and nocturia. At first consultation, 71% of patients recalled providing a urine sample, 57% having a blood test for prostate-specific antigen and 56% a digital rectal examination being performed. Over two thirds of patients (69%) were satisfied with their current medication; highest satisfaction rates (among both patients and physicians) were reported for alpha blockers and 5ARIs, either as monotherapies or used in combination. Patients were prepared to wait longer for symptom relief in order to have a reduced risk of surgery. Most physicians (90%) thought that at least some patients believe BPH/LUTS to be a progressive condition. Most physicians thought that patients were very/fairly concerned about BPH surgery (92%) and acute urinary retention (72%); 52% of physicians thought treatment adherence was "extremely" important.
  
  
  CONCLUSIONS
  This study provides valuable insights into the attitudes and beliefs of patients and physicians in Asia Pacific, Latin America and CIS about BPH/LUTS and its management. It also highlights areas of discordance between patient/physician perceptions and beliefs about BPH/LUTS, and potential areas of focus to improve the experience of affected patients.
authors: GlaxoSmithKline, Durham, NC, USA. pertel@nc.rr.com.
authors: Phillip
authors: P
authors: Ertel
authors: GlaxoSmithKline, Istanbul, Turkey.
authors: Burkay
authors: B
authors: Adalig
authors: GlaxoSmithKline, Brentford, UK.
authors: Ipek
authors: I
authors: Demircan
authors: Ipsos Healthcare, London, UK.
authors: Belinda
authors: B
authors: Lartey
authors: GlaxoSmithKline, Durham, NC, USA.
authors: Michael J
authors: MJ
authors: Manyak
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001208:Asia; D001294:Attitude to Health; D017517:Commonwealth of Independent States; D003430:Cross-Sectional Studies; D006801:Humans; D007843:Latin America; D059411:Lower Urinary Tract Symptoms / Q000523:psychology / Q000628:therapy; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D044349:Oceania; D057240:Patient Preference; D017060:Patient Satisfaction; D011470:Prostatic Hyperplasia / Q000523:psychology* / Q000628:therapy; D011788:Quality of Life; D011795:Surveys and Questionnaires